ScholarIQanswers from OpenAlex
Hôpital privé du Confluent
InstitutionResearch output, impact & collaborations
Hôpital privé du Confluent is a institution indexed in ScholarIQ from OpenAlex.
What is known about Hôpital privé du Confluent?
ScholarIQrecord summary
Hôpital privé du Confluent is a research organisation in Nantes, FR. OpenAlex records 512 works and 10,435 citations for it. 134 researchers list it as their most recent affiliation.
How many works does Hôpital privé du Confluent have?
ScholarIQindexed works
Hôpital privé du Confluent has 512 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hôpital privé du Confluent have?
ScholarIQcitation count
Hôpital privé du Confluent has 10,435 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Hôpital privé du Confluent?
ScholarIQresearcher count
Hôpital privé du Confluent has 134 researchers in the ScholarIQ index.
What is the average h-index at Hôpital privé du Confluent?
ScholarIQavg h-index
Hôpital privé du Confluent has an average h-index of 52 in OpenAlex.
What is the ROR of Hôpital privé du Confluent?
ScholarIQror
The ROR for Hôpital privé du Confluent is on the source record.
What is the OpenAlex record for Hôpital privé du Confluent?
ScholarIQopenalex
The OpenAlex for Hôpital privé du Confluent is on the source record.
Who are the most-cited researchers behind Hôpital privé du Confluent?
ScholarIQtop researchers by citations
What are the most-cited papers on Hôpital privé du Confluent?
ScholarIQmost cited works
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder, Andreas du Bois, Jalid Sehouli, Rainer Kimmig, Anne Stähle, Fiona Collinson, Sharadah Essapen, Charlie Gourley, Alain Lortholary, Frédèric Selle, Mansoor R. Mirza, Arto Leminen, Marie Plante, Dan Stark, Wendi Qian, Mahesh Parmar, Amit M. Oza
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Isabelle Ray‐Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martı́n, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Frédèric Selle, Jalid Sehouli, Domenica Lorusso, Eva María Guerra Alia, Alexander Reinthaller, Shoji Nagao, Claudia Lefeuvre‐Plesse, Ulrich Canzler, Giovanni Scambia, Alain Lortholary, Frederik Marmé, Pierre Combe, Nikolaus de Gregorio, Manuel Rodrigues, Paul Buderath, Coraline Dubot, Alexander Burges, Benoît You, Éric Pujade-Lauraine, Philipp Harter
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
François‐Clément Bidard, François-Clément Bidard, Anne‐Claire Hardy‐Bessard, Florence Dalenc, Thomas Bachelot, Jean-Yves Pierga, Thibault de la Motte Rouge, Renaud Sabatier, Coraline Dubot, Jean-Sébastien Frenel, Jean Marc Ferrero, Sylvain Ladoire, Christelle Levy, Marie-Ange Mouret-Reynier, Alain Lortholary, Julien Grenier, Camille Chakiba, Laetitia Stefani, Jérôme Edouard Plaza, Florian Clatot, Luis Teixeira, Véronique D'Hondt, Hélène Vegas, Olfa Derbel, Claire Garnier-Tixidré, Jean-Luc Canon, Barbara Pistilli, Fabrice André, Laurent Arnould, Anne Pradines, Ivan Bièche, Céline Callens, Jérôme Lemonnier, Frédérique Berger, Suzette Delaloge, Francois-Clement BIDARD, Francois-Clement BIDARD, Barbara PISTILLI, Florence DALENC, Thomas BACHELOT, Thibault De La Motte Rouge, Renaud SABATIER, Coraline DUBOT, Jean-Sébastien FRENEL, Jean-Marc FERRERO, Sylvain Ladoire, Christelle LEVY, Marie-Ange MOURET-REYNIER, Anne-Claire HARDY-BESSARD, Alain Lortholary, Julien GRENIER, Camille Chakiba, Laetitia STEFANI, P Soulié, Jean-Philippe Jacquin, Jérôme Edouard PLAZA, Florian CLATOT, Luis TEIXEIRA, Véronique D’Hondt, Hélène VEGAS, Olfa DERBEL, Claire Garnier Tixidre, Catherine Delbaldo, Lionel MOREAU, Caroline Cheneau, Jean-François Paitel, Chantal BERNARD-MARTY, Dominique Spaëth, Dominique Genet, Isabelle MOULLET, Nathalie BONICHON-LAMICHHANE, Laura DEIANA, Charlotte GREILSAMER, Laurence Venat‐Bouvet, Valérie Delecroix, Adrien MELIS, Hubert Orfeuvre, Suzanne Nguyen, Éric Legouffe, Alain Zannetti, Romuald Le Scodan, Nadine Dohollou, Philippe DALIVOUST, Olivier Arsène, Nathalie MARQUES, Thierry Petit, Delphine MOLLON, Jérôme Dauba, Nathalie Bonnin, François MORVAN, Miriam Gardner, Adina MARTI, Charles-Briac Levaché, Emma Lachaier, Mihaela ACHILLE, Christophe VALMAR, Ryan Bouaita, Jacques Médioni, Cyril Foa, Chantal BERNARD-MARTY
How much of the research on Hôpital privé du Confluent is open access?
ScholarIQopen access share
67%OPEN ACCESS